Publications

What if acting on the cells surrounding the tumour could improve the effectiveness of treatments? On 14 September 2022, a team from the SIRIC ILIAD specialising in breast cancer published a [...]

Last August, Professor Philippe Moreau, haematologist and director of SIRIC ILIAD, published a scientific article in the prestigious New England Journal of Medicine, alongside some thirty [...]

What if managers’ emotional skills could help improve employees’ return to work after cancer? Marie Viseux, a doctoral student in the SIRIC ILIAD’s ReWork programme, has [...]

Is physical activity a lever for a return to work after cancer? This question was the subject of a study conducted by researchers from the SIRIC ILIAD ReWork programme, whose results were [...]

Last June, Professors Philippe Moreau and Cyrille Touzeau, both haematologists and researchers at SIRIC ILIAD, published a scientific article in Blood, THE specialist haematology journal. Every [...]

The Loire-Atlantique Vendée Cancer Registry publishes two updated reports for each of its departments Le Registre des Cancers Loire-Atlantique Vendée, partenaire du SIRIC ILIAD, a publié comme [...]

Nantes research on astatine in the spotlight Astatine (At) is the rarest chemical element on Earth, and its 211 isotope is very promising for applications in targeted radiotherapy of cancers. [...]

As part of the work carried out on tumour resistance, the SIRIC ILIAD teams are proud to announce the publication of the article “Paracaspase MALT1 regulates glioma cell survival by [...]